(NASDAQ:MRVI), RADNOR, Pa., March 23, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those […]

(NYSE:ELF), NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. SO WHAT:

HashKey Chain announced that the tokenized USD Money Market Fund, “CPIC Estable MMF”, initiated and managed by CPIC Investment Management (H.K.) Co, Ltd, was successfully deployed on HashKey Chain, with subscription volume reaching USD 100 million on its launch day. This deployment enhances HashKey Chain's position in the institutional DeFi sector and solidifies its status

HashKey Chain announced that the tokenized USD Money Market Fund, “CPIC Estable MMF”, initiated and managed by CPIC Investment Management (H.K.) Co, Ltd, was successfully deployed on HashKey Chain, with subscription volume reaching USD 100 million on its launch day. This deployment enhances HashKey Chain's position in the institutional DeFi sector and solidifies its status

Impact fund manager Abler Nordic has partnered withTemasek Foundation, a Singapore-based philanthropic organisation that drives impact programmes in Asia, together with sustainable palm oil producer Musim Mas, and Livelihoods Funds to launch the Sustainable Oil Palm Replanting in Indonesia (SOPRI) project. The pilot initiative facilitates access to financing and resources for smallholders to sustainably replant

— Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib — Nearly all myelofibrosis patients globally are estimated to develop anaemia over the course of the disease, and over 30% will discontinue treatment due to anaemia[1-3] — Omjjara addresses the key manifestations of myelofibrosis,

Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare As the demand for surgical precision and faster patient recovery continues to grow, smart healthcare has achieved another major breakthrough. Since 2006, ChangGung Memorial Hospital has pioneered the use of the Da Vinci Robotic Surgical Systems. By the end of 2024, the hospital had

FuSure Reinsurance (“FuSure”) is pleased to announce that, following four years of steady growth, it has successfully secured a long-term insurance authorization (Class A and Class D) from the Hong Kong Insurance Authority (HKIA), and upgraded its existing General Insurance operations into a Composite License. This license upgrade represents a significant milestone in FuSure's strategic

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received 2025 CDMO Leadership Awards in the “Biologics – Global” category. It has also been recognized for excellence in “Best Scientific Expertise”, “Best Seamless Delivery Across Phases”, “Best Innovative Approach to Technology and Process Execution”, making

CStone Pharmaceuticals (“CStone”, HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of aType II variation applicationto the European Medicines Agency (EMA) forsugemalimab. The application seeks approval for the treatment ofpatients with unresectable stage III non-small cell lung cancer (NSCLC) who have not progressed following concurrent or sequential platinum-based